Bastiaan Sallevelt

421 General Discussion 29. Anrys P, Boland B, Degryse JM, De Lepeleire J, Petrovic M, Marien S, et al. STOPP/ START version 2-development of software applications: Easier said than done? Age Ageing 2016;45:590–3. https://doi.org/10.1093/ageing/afw114. 30. Huibers CJA, Sallevelt BTGM, de Groot DA, Boer MJ, van Campen JPCM, Davids CJ, et al. Conversion of STOPP/START version 2 into coded algorithms for software implementation: A multidisciplinary consensus procedure. Int J Med Inform 2019;125:110–7. https://doi.org/10.1016/j.ijmedinf.2018.12.010. 31. Agrawal A. Medication errors: Prevention using information technology systems. Br J Clin Pharmacol 2009;67:681–6. https://doi.org/10.1111/j.1365-2125.2009.03427.x. 32. Pfeffer J, Sutton R. The Knowing-Doing Gap: How Smart Companies Turn Knowledge into Action. Harvard Business School Press; 2000. 33. Damoiseaux-Volman BA, Medlock S, Ploegmakers KJ, Karapinar-Çarkit F, Krediet CTP, de Rooij SE, et al. Priority Setting in Improving Hospital Care for Older Patients Using Clinical Decision Support. J Am Med Dir Assoc 2019;20:1045–7. https://doi. org/10.1016/j.jamda.2019.03.017. 34. Van Der Sijs H, Mulder A, Van Gelder T, Aarts J, Berg M, Vulto A. Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol Drug Saf 2009. https://doi.org/10.1002/pds.1800. 35. Singhal S, Krishnamurthy A, Wang B, Weng Y, Sharp C, Shah N, et al. Effect of electronic clinical decision support on inappropriate prescriptions in older adults. J Am Geriatr Soc 2022;70:905–8. https://doi.org/10.1111/jgs.17608. 36. Pollock M, Bazaldua O V., Dobbie AE. Appropriate prescribing of medications: An eightstep approach. Am Fam Physician 2007;75:231–6. 37. De Vries T, Henning R, Hogerzeil H, Fresle D. Guide to Good Prescribing. World Heal Organ 1995:1–142. https://apps.who.int/iris/handle/10665/59001 (accessed May 30, 2022). 38. Nuckols TK, Smith-Spangler C, Morton SC, Asch SM, Patel VM, Anderson LJ, et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: A systematic review and meta-analysis. Syst Rev 2014;3:1–12. https://doi.org/10.1186/2046-4053-3-56. 39. Wasylewicz A, van de Burgt B, Weterings A, Jessurun N, Korsten E, Egberts T, et al. Identifying adverse drug reactions from free-text electronic hospital health record notes. Br J Clin Pharmacol 2022. https://doi.org/10.1111/bcp.15068. 40. Wasylewicz A, van de Burgt B, Manten T, Kerskes M, Compagner W, Korsten E, et al. Contextualized drug-drug interaction management improves clinical utility compared to basic drug-drug interaction management in hospitalized patients. Clin Pharmacol Ther 2022:Epub ahead of print. https://doi.org/10.1002/cpt.2624. 41. Keijsers CJPW, Van Doorn ABD, Van Kalles A, De Wildt DJ, Brouwers JRBJ, Van De Kamp HJ, et al. Structured pharmaceutical analysis of the systematic tool to reduce inappropriate prescribing is an effective method for final-year medical students to improve polypharmacy skills: A randomized controlled trial. J Am Geriatr Soc 2014;62:1353–9. https://doi.org/10.1111/jgs.12884. 42. NICE, Medicines and CUP. Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes. NICE Guidel 2015. https://www.nice. org.uk/guidance/ng5 (accessed May 30, 2022). 43. Holman H. Which clinical studies provide the best evidence? Bmj 2000;321:255–6. 44. Huibers CJA, Sallevelt BTGM, Heij JMJ op, O’Mahony D, Rodondi N, Dalleur O, et al. Hospital physicians’ and older patients’ agreement with individualised STOPP/STARTbased medication optimisation recommendations in a clinical trial setting. Eur Geriatr Med 2022. https://doi.org/10.1007/s41999-022-00633-5. 5

RkJQdWJsaXNoZXIy MTk4NDMw